Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Martek trims Kentucky operations

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences reduces its Winchester, Ky., workforce by about 45 people, nearly half its staffing at the facility, to offset infant formula price reductions, streamline operations and improve use of manufacturing capacity. Some manufacturing and distribution will move to Martek's Kingstree, S.C., site from Winchester, which lost about 100 workers during a 2006 restructuring (1"The Tan Sheet" Oct. 30, 2006). Martek expects to incur a non-cash asset impairment charge from the restructuring of $30 million to $40 million in the second half of its fiscal 2010. The Columbia, Md., nutritional oils firm said June 30 it plans to continue operations in Winchester, but potentially may sell or lease part of the facility

You may also be interested in...

Martek Expects Growth With Restructuring Plan, Including Layoffs

Martek Biosciences continues to push its growth with a new restructuring plan that should make it leaner and meaner, according to an Oct. 26 release

France Rejects Advice To Delay Second Dose Of Pfizer Vaccine

The French government has decided not to extend the recommended interval between the two doses of the Pfizer/BioNTech coronavirus vaccine. 

Biosimilars Boost Offsets Generics Slide For Sandoz

Despite the turbulence of 2020 and the pressures of the coronavirus pandemic, Sandoz has reported steady sales for the year, as biopharmaceuticals sales up by a fifth offset a slide in turnover from retail generics.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts